Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.27 and traded as low as $0.26. Northwest Biotherapeutics shares last traded at $0.27, with a volume of 3,451,659 shares.
Northwest Biotherapeutics Trading Up 7.6%
The company has a fifty day simple moving average of $0.27 and a 200-day simple moving average of $0.27. The stock has a market cap of $391.05 million, a price-to-earnings ratio of -3.38 and a beta of -1.09.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last posted its quarterly earnings data on Thursday, May 15th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.38 million during the quarter.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Recommended Stories
- Five stocks we like better than Northwest Biotherapeutics
- What is Insider Trading? What You Can Learn from Insider Trading
- Five Below Pops on Strong Earnings, But Rally May Stall
- Why Are Stock Sectors Important to Successful Investing?
- Intel’s Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
- Most active stocks: Dollar volume vs share volume
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
